logo

STIM

Neuronetics·NASDAQ
--
--(--)
--
--(--)
1.61 / 10
Underperform

Fundamental evaluation presents weak characteristics (1.6/10). Strengths encompass Net profit attributable to parent company shareholders / Net profit (%) and Cash-UP, although drawbacks are visible in Revenue-MV and Net income-Revenue. This justifies constrained view.

Fundamental(1.61)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value0.14
Score0/3
Weight16.51%
1M Return-3.84%
ROA (%)
Value-22.30
Score2/3
Weight1.74%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.72
Score2/3
Weight7.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight10.68%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight18.44%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-29.73
Score2/3
Weight1.74%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.53%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight2.97%
1M Return-0.63%
Cash-MV
Value-0.07
Score1/3
Weight20.26%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight11.57%
1M Return-2.89%
Is STIM undervalued or overvalued?
  • STIM scores 1.61/10 on fundamentals and holds a Premium valuation at present. Backed by its -100.82% ROE, -34.35% net margin, -2.40 P/E ratio, 3.41 P/B ratio, and 31.97% earnings growth, these metrics solidify its Underperform investment rating.